Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 111

1.

The German Hodgkin Study Group risk model is useful for Hodgkin lymphoma patients receiving radiotherapy after autologous stem cell transplant.

Furlan C, Matrone F, Rupolo M, Ciancia R, Zanet E, Montante B, Palazzari E, Navarria F, Trovo M, Bulian P, Spina M, Coassin E, Mascarin M, De Paoli A, Franchin G, Michieli M.

Cancer Radiother. 2019 Sep;23(5):378-384. doi: 10.1016/j.canrad.2019.02.002. Epub 2019 Jun 6.

PMID:
31178272
2.

Direct health-care cost of head and neck cancers: a population-based study in north-eastern Italy.

Polesel J, Lupato V, Collarile P, Vaccher E, Fanetti G, Giacomarra V, Palazzari E, Furlan C, Matrone F, Navarria F, Gobitti C, Minatel E, Serraino D, Birri S, Franchin G.

Med Oncol. 2019 Feb 28;36(4):31. doi: 10.1007/s12032-019-1256-2.

PMID:
30815763
3.

Optimization and Characterization of Preceramic Inks for Direct Ink Writing of Ceramic Matrix Composite Structures.

Franchin G, Maden HS, Wahl L, Baliello A, Pasetto M, Colombo P.

Materials (Basel). 2018 Mar 28;11(4). pii: E515. doi: 10.3390/ma11040515.

4.

Malignant struma ovarii harboring a unique NRAS mutation: case report and review of the literature.

Gobitti C, Sindoni A, Bampo C, Baresic T, Giorda G, Alessandrini L, Canzonieri V, Franchin G, Borsatti E.

Hormones (Athens). 2017 Jul;16(3):322-327. doi: 10.14310/horm.2002.1750. Review.

5.

Real-practice thromboprophylaxis in atrial fibrillation.

Deambrosis P, Bettiol A, Bolcato J, Pirolo R, Franchin G, Themistoclakis S, Pellizzari M, Chinellato A, Giusti P.

Acta Pharm. 2017 Jun 27;67(2):227-236. doi: 10.1515/acph-2017-0016.

PMID:
28590907
6.

Prognostic significance of LINE-1 hypomethylation in oropharyngeal squamous cell carcinoma.

Furlan C, Polesel J, Barzan L, Franchin G, Sulfaro S, Romeo S, Colizzi F, Rizzo A, Baggio V, Giacomarra V, Dei Tos AP, Boscolo-Rizzo P, Vaccher E, Dolcetti R, Sigalotti L, Fratta E.

Clin Epigenetics. 2017 May 30;9:58. doi: 10.1186/s13148-017-0357-z. eCollection 2017.

7.

The molten glass sewing machine.

Brun PT, Inamura C, Lizardo D, Franchin G, Stern M, Houk P, Oxman N.

Philos Trans A Math Phys Eng Sci. 2017 May 13;375(2093). pii: 20160156. doi: 10.1098/rsta.2016.0156.

8.

The impact of time to treatment initiation on survival from head and neck cancer in north-eastern Italy.

Polesel J, Furlan C, Birri S, Giacomarra V, Vaccher E, Grando G, Gobitti C, Navarria F, Schioppa O, Minatel E, Bidoli E, Barzan L, Franchin G.

Oral Oncol. 2017 Apr;67:175-182. doi: 10.1016/j.oraloncology.2017.02.009. Epub 2017 Mar 3.

PMID:
28351574
9.

An Integrated Approach Identifies Mediators of Local Recurrence in Head and Neck Squamous Carcinoma.

Citron F, Armenia J, Franchin G, Polesel J, Talamini R, D'Andrea S, Sulfaro S, Croce CM, Klement W, Otasek D, Pastrello C, Tokar T, Jurisica I, French D, Bomben R, Vaccher E, Serraino D, Belletti B, Vecchione A, Barzan L, Baldassarre G.

Clin Cancer Res. 2017 Jul 15;23(14):3769-3780. doi: 10.1158/1078-0432.CCR-16-2814. Epub 2017 Feb 7.

10.

Adherence to the World Cancer Research Fund/American Institute for Cancer Research recommendations and head and neck cancers risk.

Bravi F, Polesel J, Garavello W, Serraino D, Negri E, Franchin G, La Vecchia C, Bosetti C.

Oral Oncol. 2017 Jan;64:59-64. doi: 10.1016/j.oraloncology.2016.11.012. Epub 2016 Dec 3.

PMID:
28024725
11.

Low-dose radiotherapy in diffuse large B-cell lymphoma.

Furlan C, Canzonieri V, Spina M, Michieli M, Ermacora A, Maestro R, Piccinin S, Bomben R, Dal Bo M, Trovo M, Gattei V, Tirelli U, Franchin G, Bulian P.

Hematol Oncol. 2017 Dec;35(4):472-479. doi: 10.1002/hon.2368. Epub 2016 Oct 25.

PMID:
27781290
12.

Metabolic disorders and the risk of nasopharyngeal carcinoma: a case-control study in Italy.

Zucchetto A, Taborelli M, Bosetti C, Montella M, La Vecchia C, Franchin G, Libra M, Serraino D, Polesel J.

Eur J Cancer Prev. 2018 Mar;27(2):180-183. doi: 10.1097/CEJ.0000000000000286.

PMID:
27479542
13.

Broadening Specificity and Enhancing Cytotoxicity of Adoptive T Cells for Nasopharyngeal Carcinoma Immunotherapy.

Faè DA, Martorelli D, Mastorci K, Muraro E, Dal Col J, Franchin G, Barzan L, Comaro E, Vaccher E, Rosato A, Dolcetti R.

Cancer Immunol Res. 2016 May;4(5):431-40. doi: 10.1158/2326-6066.CIR-15-0108. Epub 2016 Mar 23.

14.

Post-chikungunya rheumatic disorders in travelers after return from the Caribbean.

Zeana C, Kelly P, Heredia W, Cifuentes A, Franchin G, Purswani M, Tieng A, Hagmann SHF.

Travel Med Infect Dis. 2016 Jan-Feb;14(1):21-25. doi: 10.1016/j.tmaid.2016.01.009. Epub 2016 Jan 30.

PMID:
26872414
15.

Recurrent Thrombotic Vasculopathy in a Former Cocaine User.

Jadhav P, Tariq H, Niazi M, Franchin G.

Case Rep Dermatol Med. 2015;2015:763613. doi: 10.1155/2015/763613. Epub 2015 Dec 17.

16.

Etanercept-induced myositis: do we have to stop it? A surprising outcome.

Tariq H, Ayesha B, Weidenheim K, Franchin G.

BMJ Case Rep. 2016 Jan 11;2016. pii: bcr2015213577. doi: 10.1136/bcr-2015-213577.

17.

Stereolithography of SiOC Ceramic Microcomponents.

Zanchetta E, Cattaldo M, Franchin G, Schwentenwein M, Homa J, Brusatin G, Colombo P.

Adv Mater. 2016 Jan 13;28(2):370-6. doi: 10.1002/adma.201503470. Epub 2015 Nov 6.

PMID:
26545292
18.

Cell-free DNA as a prognostic marker in stage I non-small-cell lung cancer patients undergoing stereotactic body radiotherapy.

Bortolin MT, Tedeschi R, Bidoli E, Furlan C, Basaglia G, Minatel E, Gobitti C, Franchin G, Trovò M, De Paoli P.

Biomarkers. 2015;20(6-7):422-8. doi: 10.3109/1354750X.2015.1094139. Epub 2015 Nov 2.

PMID:
26526078
19.

Lower platelet counts and antiplatelet therapy independently predict better outcomes in patients with head and neck squamous cell carcinoma: a retrospective analysis.

Furlan C, Steffan A, Polesel J, Trovo M, Gobitti C, Vaccher E, Serraino D, Barzan L, Franchin G.

Biomark Res. 2015 Oct 6;3:25. doi: 10.1186/s40364-015-0051-2. eCollection 2015.

20.

Radical Radiation Therapy After Lung-Sparing Surgery for Malignant Pleural Mesothelioma: Survival, Pattern of Failure, and Prognostic Factors.

Minatel E, Trovo M, Bearz A, Di Maso M, Baresic T, Drigo A, Barresi L, Furlan C, Del Conte A, Bruschi G, Fontana P, Pagan V, Franchin G.

Int J Radiat Oncol Biol Phys. 2015 Nov 1;93(3):606-13. doi: 10.1016/j.ijrobp.2015.06.029. Epub 2015 Jun 20.

PMID:
26281826
21.

Effectiveness of selective neck dissection in head and neck cancer: the experience of two Italian centers.

Barzan L, Talamini R, Franchin G, Pin M, Silvestrini M, Grando G, Galla S, Savignano MG, Armas G, Margiotta F, Vanoni V, Magri E, Grandi C.

Laryngoscope. 2015 Aug;125(8):1849-55. doi: 10.1002/lary.25296. Epub 2015 Apr 17.

PMID:
25891410
22.

Combined effect of tobacco smoking and alcohol drinking in the risk of head and neck cancers: a re-analysis of case-control studies using bi-dimensional spline models.

Dal Maso L, Torelli N, Biancotto E, Di Maso M, Gini A, Franchin G, Levi F, La Vecchia C, Serraino D, Polesel J.

Eur J Epidemiol. 2016 Apr;31(4):385-93. doi: 10.1007/s10654-015-0028-3. Epub 2015 Apr 9.

PMID:
25855002
23.

Collapsing focal segmental glomerulosclerosis in a patient with systemic lupus erythematosus.

Tariq H, Rafiq A, Franchin G.

Case Rep Med. 2014;2014:732192. doi: 10.1155/2014/732192. Epub 2014 Aug 11.

24.

Head and neck cancer survivors patients and late effects related to oncologic treatment: update of literature.

Taibi R, Lleshi A, Barzan L, Fiorica F, Leghissa M, Vaccher E, De Paoli P, Franchin G, Berretta M, Tirelli U.

Eur Rev Med Pharmacol Sci. 2014;18(10):1473-81. Review.

25.

Stereotactic body radiation therapy for re-irradiation of persistent or recurrent non-small cell lung cancer.

Trovo M, Minatel E, Durofil E, Polesel J, Avanzo M, Baresic T, Bearz A, Del Conte A, Franchin G, Gobitti C, Rumeileh IA, Trovo MG.

Int J Radiat Oncol Biol Phys. 2014 Apr 1;88(5):1114-9. doi: 10.1016/j.ijrobp.2014.01.012.

PMID:
24661664
26.

Radical pleurectomy/decortication followed by high dose of radiation therapy for malignant pleural mesothelioma. Final results with long-term follow-up.

Minatel E, Trovo M, Polesel J, Baresic T, Bearz A, Franchin G, Gobitti C, Rumeileh IA, Drigo A, Fontana P, Pagan V, Trovo MG.

Lung Cancer. 2014 Jan;83(1):78-82. doi: 10.1016/j.lungcan.2013.10.013. Epub 2013 Oct 27.

PMID:
24216141
27.

Concurrent chemoradiotherapy with tomotherapy in locally advanced Non-Small Cell Lung Cancer: a phase I, docetaxel dose-escalation study, with hypofractionated radiation regimen.

Bearz A, Minatel E, Rumeileh IA, Borsatti E, Talamini R, Franchin G, Gobitti C, Del Conte A, Trovò M, Baresic T.

BMC Cancer. 2013 Oct 31;13:513. doi: 10.1186/1471-2407-13-513.

28.

Fiber intake and risk of nasopharyngeal carcinoma: a case-control study.

Bidoli E, Pelucchi C, Polesel J, Negri E, Barzan L, Franchin G, Franceschi S, Serraino D, De Paoli P, La Vecchia C, Talamini R.

Nutr Cancer. 2013;65(8):1157-63. doi: 10.1080/01635581.2013.828088. Epub 2013 Oct 7.

PMID:
24098992
29.

Anti-DNA antibodies cross-react with C1q.

Franchin G, Son M, Kim SJ, Ben-Zvi I, Zhang J, Diamond B.

J Autoimmun. 2013 Aug;44:34-9. doi: 10.1016/j.jaut.2013.06.002. Epub 2013 Jul 5.

30.

Tomotherapy after pleurectomy/decortication or biopsy for malignant pleural mesothelioma allows the delivery of high dose of radiation in patients with intact lung.

Minatel E, Trovo M, Polesel J, Rumeileh IA, Baresic T, Bearz A, Del Conte A, Franchin G, Gobitti C, Drigo A, Dassie A, Pagan V, Trovo MG.

J Thorac Oncol. 2012 Dec;7(12):1862-1866. doi: 10.1097/JTO.0b013e318272601f.

31.

Dose to the skin in helical tomotherapy: results of in vivo measurements with radiochromic films.

Avanzo M, Drigo A, Ren Kaiser S, Roggio A, Sartor G, Chiovati P, Franchin G, Mascarin M, Capra E.

Phys Med. 2013 May;29(3):304-11. doi: 10.1016/j.ejmp.2012.04.004. Epub 2012 May 8.

PMID:
22575703
32.

Treatment of recurrent high-grade gliomas with GliaSite brachytherapy: a prospective mono-institutional Italian experience.

Gobitti C, Borsatti E, Arcicasa M, Roncadin M, Franchin G, Minatel E, Skrap M, Zanotti B, Tuniz F, Cimitan M, Capra E, Drigo A, Trovò MG.

Tumori. 2011 Sep-Oct;97(5):614-9. doi: 10.1700/989.10721.

PMID:
22158493
33.

Intensity-modulated radiotherapy (IMRT)/Tomotherapy following neoadjuvant chemotherapy in stage IIB-IVA/B undifferentiated nasopharyngeal carcinomas (UCNT): a mono-institutional experience.

Franchin G, Vaccher E, Talamini R, Politi D, Gobitti C, Minatel E, Lleshi A, Sartor G, Mascarin M, Rumeileh IA, Trovò MG, Barzan L.

Oral Oncol. 2011 Sep;47(9):905-9. doi: 10.1016/j.oraloncology.2011.06.503. Epub 2011 Jul 23.

PMID:
21783403
34.

Tobacco smoking, alcohol drinking, and the risk of different histological types of nasopharyngeal cancer in a low-risk population.

Polesel J, Franceschi S, Talamini R, Negri E, Barzan L, Montella M, Libra M, Vaccher E, Franchin G, La Vecchia C, Serraino D.

Oral Oncol. 2011 Jun;47(6):541-5. doi: 10.1016/j.oraloncology.2011.03.017. Epub 2011 Apr 7.

PMID:
21478046
35.

Alteration of G1/S transition regulators influences recurrences in head and neck squamous carcinomas.

Canzonieri V, Barzan L, Franchin G, Vaccher E, Talamini R, Sulfaro S, Baldassarre G.

J Cell Physiol. 2012 Jan;227(1):233-8. doi: 10.1002/jcp.22723.

PMID:
21412768
36.

Helical tomotherapy in children and adolescents: dosimetric comparisons, opportunities and issues.

Mascarin M, Giugliano FM, Coassin E, Drigo A, Chiovati P, Dassie A, Franchin G, Minatel E, Trovò MG.

Cancers (Basel). 2011 Oct 25;3(4):3972-90. doi: 10.3390/cancers3043972.

37.

Optimizing craniospinal radiotherapy delivery in a pediatric patient affected by supratentorial PNET: a case report.

Mascarin M, Drigo A, Dassie A, Gigante M, Franchin G, Sartor G, Trovò MG.

Tumori. 2010 Mar-Apr;96(2):316-21. Erratum in: Tumori. 2010 May-Jun;96(3):513.

PMID:
20572592
38.

Correlation of a hypoxia based tumor control model with observed local control rates in nasopharyngeal carcinoma treated with chemoradiotherapy.

Avanzo M, Stancanello J, Franchin G, Sartor G, Jena R, Drigo A, Dassie A, Gigante M, Capra E.

Med Phys. 2010 Apr;37(4):1533-44.

PMID:
20443474
39.

Undifferentiated nasopharyngeal carcinoma from a nonendemic area: protective role of HLA allele products presenting conserved EBV epitopes.

Pasini E, Caggiari L, Dal Maso L, Martorelli D, Guidoboni M, Vaccher E, Barzan L, Franchin G, Gloghini A, De Re V, Sacchi N, Serraino D, Carbone A, Rosato A, Dolcetti R.

Int J Cancer. 2009 Sep 15;125(6):1358-64. doi: 10.1002/ijc.24515.

40.

Postoperative reduced dose of cisplatin concomitant with radiation therapy in high- risk head and neck squamous cell carcinoma.

Franchin G, Minatel E, Politi D, Gobitti C, Talamini R, Vaccher E, Savignano MG, Trovo M, Sulfaro S, Barzan L.

Cancer. 2009 Jun 1;115(11):2464-71. doi: 10.1002/cncr.24252.

41.

Organ preservation in locally advanced head and neck cancer of the larynx using induction chemotherapy followed by improved radiation schemes.

Franchin G, Vaccher E, Politi D, Minatel E, Gobitti C, Talamini R, Spazzapan S, Savignano MG, Trovò MG, Barzan L.

Eur Arch Otorhinolaryngol. 2009 May;266(5):719-26. doi: 10.1007/s00405-008-0798-2. Epub 2008 Sep 9.

PMID:
18779973
42.

Detection and restaging of residual and/or recurrent nasopharyngeal carcinoma after chemotherapy and radiation therapy: comparison of MR imaging and FDG PET/CT.

Comoretto M, Balestreri L, Borsatti E, Cimitan M, Franchin G, Lise M.

Radiology. 2008 Oct;249(1):203-11. doi: 10.1148/radiol.2491071753. Epub 2008 Aug 18.

PMID:
18710963
43.

A phase I/II trial of gefitinib and radiotherapy in patients with locally advanced inoperable squamous cell carcinoma of the head and neck.

Caponigro F, Romano C, Milano A, Solla R, Franchin G, Adamo V, Mari E, Morrica B, Pepe S.

Anticancer Drugs. 2008 Aug;19(7):739-44. doi: 10.1097/CAD.0b013e32830676a8.

PMID:
18594217
44.

Spontaneous T cell responses to Epstein-Barr virus-encoded BARF1 protein and derived peptides in patients with nasopharyngeal carcinoma: bases for improved immunotherapy.

Martorelli D, Houali K, Caggiari L, Vaccher E, Barzan L, Franchin G, Gloghini A, Pavan A, Da Ponte A, Tedeschi RM, De Re V, Carbone A, Ooka T, De Paoli P, Dolcetti R.

Int J Cancer. 2008 Sep 1;123(5):1100-7. doi: 10.1002/ijc.23621.

45.

High serum levels of soluble CD40-L in patients with undifferentiated nasopharyngeal carcinoma: pathogenic and clinical relevance.

Caggiari L, Guidoboni M, Vaccher E, Barzan L, Franchin G, Gloghini A, Martorelli D, Zancai P, Bortolin MT, Mazzucato M, Serraino D, Carbone A, De Paoli P, Dolcetti R.

Infect Agent Cancer. 2007 Mar 1;2:5.

46.

Long-term results of conventional radiotherapy versus accelerated hyperfractionated radiotherapy versus concomitant radiotherapy and chemotherapy in locoregionally advanced carcinoma of the oropharynx.

Fallai C, Bolner A, Signor M, Gava A, Franchin G, Ponticelli P, Taino R, Rossi F, Ardizzoia A, Oggionni M, Crispino S, Olmi P.

Tumori. 2006 Jan-Feb;92(1):41-54.

PMID:
16683383
47.

Pulse steroids: how much is enough?

Franchin G, Diamond B.

Autoimmun Rev. 2006 Feb;5(2):111-3. Epub 2005 Aug 29. Review.

PMID:
16431338
48.

Thoracic radiation therapy and concomitant low-dose daily paclitaxel in non-small cell lung cancer: a phase I study.

Gobitti C, Franchin G, Minatel E, Gigante M, Basso B, Bujor L, Trovò MG.

Oncol Rep. 2005 Dec;14(6):1647-53.

PMID:
16273271
49.

Interleukin-10 and interleukin-18 promoter polymorphisms in an Italian cohort of patients with undifferentiated carcinoma of nasopharyngeal type.

Pratesi C, Bortolin MT, Bidoli E, Tedeschi R, Vaccher E, Dolcetti R, Guidoboni M, Franchin G, Barzan L, Zanussi S, Caruso C, De Paoli P.

Cancer Immunol Immunother. 2006 Jan;55(1):23-30. Epub 2005 Oct 27.

PMID:
16059673
50.

Role of Rho family GTPases in CCR1- and CCR5-induced actin reorganization in macrophages.

Di Marzio P, Dai WW, Franchin G, Chan AY, Symons M, Sherry B.

Biochem Biophys Res Commun. 2005 Jun 17;331(4):909-16.

PMID:
15882964

Supplemental Content

Loading ...
Support Center